Literature DB >> 35479112

Measurement of mitochondrial respiratory chain enzymatic activities in Drosophila melanogaster samples.

Michele Brischigliaro1, Elena Frigo1, Erika Fernandez-Vizarra2, Paolo Bernardi1, Carlo Viscomi1.   

Abstract

Mitochondrial respiratory chain (MRC) dysfunction is linked to mitochondrial disease as well as other common conditions such as diabetes, neurodegeneration, cancer, and aging. Thus, the evaluation of MRC enzymatic activities is fundamental for diagnostics and research purposes on experimental models. Here, we provide a verified and reliable protocol for mitochondria isolation from various D. melanogaster samples and subsequent measurement of the activity of MRC complexes I-V plus citrate synthase (CS) through UV-VIS spectrophotometry. For complete details on the use and execution of this protocol, please refer to Brischigliaro et al. (2021).
© 2022 The Author(s).

Entities:  

Keywords:  Cell separation/fractionation; Metabolism; Model Organisms; Protein Biochemistry

Mesh:

Substances:

Year:  2022        PMID: 35479112      PMCID: PMC9036317          DOI: 10.1016/j.xpro.2022.101322

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

This protocol describes step-by-step how to measure the enzymatic activity of the MRC complexes in isolated mitochondria obtained from different Drosophila melanogaster tissues. Firstly, mitochondria are separated from homogenized tissues through differential centrifugation using a sucrose-based buffer. Then, mitochondria membranes are disrupted to allow the substrates to access the MRC complexes. Enzymatic activities of individual MRC complexes are measured using specific kinetic assays and UV-VIS spectrophotometry. The MRC activities measured in this way are often normalized to the activity of the citrate synthase, a mitochondrial matrix enzyme of the Krebs cycle that is considered as a good marker of mitochondrial volume. This detailed protocol builds on previously described methods for the isolation of mitochondria from D. melanogaster tissues (Brischigliaro et al., 2019; Brischigliaro et al., 2021) and on the procedures for measuring MRC enzymatic activities in human samples (Bugiani et al., 2004; Kirby et al., 2007; Spinazzi et al., 2012; Trounce et al., 1996). However, extensive optimization was carried out by the authors in order to provide a detailed and step-by-step procedure easy to follow also for newcomers. Essential material you must have/prepare: Biological samples: adult files or larvae. Refer to key resources table and materials and equipment to prepare reagents and buffers.

Sample collection and preparation

Timing: 0.5–2 h MRC enzymatic activities can be measured in different Drosophila samples, i.e., whole adult flies, larvae, or adult thoraces. Sample collection and preparation: Adult flies: collect 80–100 adult flies per biological replicate. Larvae: collect 80–100 third instar larvae per biological replicate. To pick up larvae, add tap water supplemented with sugar (20%) into the vials where larvae are growing and let them detach from the food or from the tube walls; when they are floating, take and wash them with PBS using a strainer. Adult thoraces: collect 120–150 thoraces per biological replicate. For dissection, anesthetize flies with CO2, quickly rinse them in 70% ethanol to remove cuticle wax. Dissect thoraces in ice-cold PBS using tweezers and precision scissors by removing the head, the abdomen, the wings and the legs. The number of larvae and thoraces should be adjusted based on their size and experimental needs. Generally, 80–100 wild-type third instar larvae or 120–150 wild-type thoraces are needed to obtain approximately 200–400 μg of isolated mitochondrial protein. This protocol can be applied to virtually any biological sample. The amount of sample must be empirically determined. Generally, 20–30 mg of tissue are needed.

Key resources table

Materials and equipment

Buffers for isolation of mitochondria and sample preparation

MS (mannitol-sucrose) buffer: Store at 4°C for 1 week. MS buffer + BSA 1%: dissolve 1.5 g of fatty acid free BSA in 150 mL of MS buffer. Store at 4°C for 1 week. Tris-HCl (10 mM pH 7.4): dissolve 61 mg of Tris base in 15 mL of distilled H2O, adjust pH to 7.4, adjust the volume to 50 mL with distilled H2O. Store at 4°C for 1 month.

Reaction buffers

Potassium phosphate monobasic (0.5 M): dissolve 6.8 g of potassium phosphate monobasic (KH2PO4) in 80 mL of distilled H2O, adjust the volume to 100 mL. Store at 4°C for 1 month. Potassium phosphate dibasic (0.5 M): dissolve 8.71 g of potassium phosphate dibasic (K2HPO4) in 80 mL of distilled H2O, adjust the volume to 100 mL. Store at 4°C for 1 month. Potassium phosphate monobasic (0.1 M): dilute 10 mL of 0.5 M potassium phosphate monobasic in 40 mL of distilled H2O. Store at 4°C for 1 month. Potassium phosphate dibasic (0.1 M): dilute 10 mL of 0.5 M potassium phosphate dibasic in 40 mL of distilled H2O. Store at 4°C for 1 month. Potassium phosphate (0.5 M pH 7.5): adjust 50 mL of 0.5 M potassium phosphate dibasic to pH 7.5 with 0.5 M potassium phosphate monobasic. Store at 4°C for 1 month. Potassium phosphate (0.1 M pH 7.0): adjust 50 mL of 0.1 M potassium phosphate dibasic to pH 7.0 with 0.1 M potassium phosphate monobasic. Store at 4°C for 1 month. Tris-HCl + Triton X-100: Store at 4°C for 1 month. HEPES-KOH + MgCl : Store at 4°C for 1 month.

Reagents for complex I (NADH:ubiquinone oxidoreductase) assay

BSA (50 mg/mL): dissolve 50 mg of fatty-acid free BSA in 1 mL of distilled H2O. Store at 4°C for 2 days or at −20°C for 1 month. KCN (10 mM): dissolve 3.3 mg of potassium cyanide (KCN) in 5 mL of distilled H2O. Prepare fresh before the assay. CRITICAL: KCN is highly toxic, under acidic conditions volatile and extremely toxic HCN species form. Handle KCN and KCN solution under a fume hood using PPE. 50 mM sodium azide (NaN3) can be used as an alternative. NADH (5 mM): dissolve 3.7 mg of β-Nicotinamide adenine dinucleotide (NADH) in 1 mL of distilled H2O. Prepare fresh before the assay. Coenzyme Q(4 mM): dissolve 2 mg of Coenzyme Q1 (CoQ1) in 2 mL of 100% ethanol. Prepare 100- μL aliquots and store at −20°C for 6 months. Rotenone (1 mM): dissolve 3.9 mg of rotenone in 10 mL of 100% ethanol. Prepare 1-mL aliquots and store and −20°C for 6 months. CRITICAL: rotenone is highly toxic, handle it under a fume hood using PPE.

Reagents for complex II (succinate:ubiquinone oxidoreductase) assay

Succinate (400 mM): dissolve 2.36 g of sodium succinate in 20 mL of distilled H2O, adjust the pH to 7.4 using NaOH, adjust the volume to 50 mL with distilled water. Store in 2-mL aliquots at −20°C for 6 months. DCPIP (500 μM): dissolve 2.9 mg of 2,6-dichlorophenolindophenol (DCPIP) in 20 mL of distilled H2O. Protect from light. Store at −20°C for 1 month. KCN (10 mM): dissolve 3.3 mg of potassium cyanide (KCN) in 5 mL of distilled H2O. Prepare fresh before the assay. CRITICAL: KCN is highly toxic, under acidic conditions volatile and extremely toxic HCN species form. Handle KCN and KCN solution under a fume hood using PPE. 50 mM sodium azide (NaN3) can be used as an alternative. Coenzyme Q(4 mM): dissolve 2 mg of Coenzyme Q1 in 2 mL of 100% ethanol. Prepare 100- μL aliquots and store at −20°C for 6 months. Malonate (1 M): dissolve 208 mg of malonic acid in 2 mL of distilled H2O. Store at −20°C for 6 months.

Reagents for complex III (ubiquinol:cytochrome c oxidoreductase) assay

EDTA (5 mM, pH 7.5): dissolve 93 mg of EDTA (ethylenediaminetetraacetic acid) in 40 mL of distilled H2O, adjust pH to 7.5 with NaOH, adjust the volume to 50 mL. Store at room temperature for 6 months. Tween-20 (2.5%): dissolve 125 μL of Tween-20 in 4.875 mL of distilled H2O. Protect from light. Prepare fresh before the assay. Cytochrome dissolve 12.4 mg in 1 mL of 20 mM potassium phosphate buffer, pH 7.0. Prepare fresh before the assay. Decylubiquinol (10 mM): dissolve 10 mg decylubiquinone in 3.1 mL of 100% ethanol. Store in 200-μL aliquots at −20°C for 6 months. To prepare decylubiquinol (reduced decylubiquinone), add few crystals of potassium borohydride to a 200-μL aliquot of decylubiquinone, add few (usually 2–4) 5 μL-aliquots of 0.1 M HCl, until the solution becomes colorless. Centrifuge at 10,000 × g for 1 min, transfer the solution to a new tube without carrying over borohydride crystals. Add few (usually 2–3) 5 μL-aliquots of 1 M HCl, until the solution stops bubbling. Keep on ice. Perform the reduction before the assay, do not store and reuse. CRITICAL: potassium borohydride is highly toxic, handle it under a fume hood using PPE. KCN (10 mM): dissolve 3.3 mg of potassium cyanide (KCN) in 5 mL of distilled H2O. Prepare fresh before the assay. CRITICAL: KCN is highly toxic, under acidic conditions volatile and extremely toxic HCN species form. Handle KCN and KCN solution under a fume hood using PPE. 50 mM sodium azide (NaN3) can be used as an alternative. Antimycin A (1 mg/mL): dissolve 4 mg of antimycin A in 4 mL of 100% ethanol. Store at −20°C for 6 months. CRITICAL: antimycin is highly toxic, handle it and dissolve under a fume hood using PPE.

Reagents for complex IV (cytochrome c oxidase) assay

Cytochrome dissolve 12.4 mg in 1 mL of 20 mM potassium phosphate buffer, pH 7.0. Add few crystals of sodium dithionite and mix, until the color of the solution switches from dark brown to orange/pink. Prepare a 20 μM solution and measure the absorbance at 550 nm and 565 nm, calculate the ratio A550/A565. Optimal values are between 6 and 8. If the ratio is lower than 6 repeat the procedure. Prepare fresh before the assay. KCN (10 mM): dissolve 3.3 mg of potassium cyanide (KCN) in 5 mL of distilled H2O. Prepare fresh before the assay. CRITICAL: KCN is highly toxic, under acidic conditions volatile and extremely toxic HCN species form. Handle KCN and KCN solution under a fume hood using PPE. 50 mM sodium azide (NaN3) can be used as an alternative.

Reagents for citrate synthase assay

DTNB (1 mM): dissolve 4 mg of 5,5′-dithiobis (2-nitrobenzoic acid), (DTNB) in 10 mL of 100 mM Tris-HCl pH 8.0. Protect from light. Prepare fresh before the assay. Acetyl-CoA (10 mM): dissolve 10 mg of Acetyl-Coenzyme A in 1.24 mL of distilled H2O. Prepare 100 μL-aliquots and store at −80°C for 6 months. Oxaloacetate (10 mM): dissolve 2.6 mg of oxaloacetic acid in 2 mL of distilled H2O. Prepare fresh before the assay.

Reagents for complex V (ATP synthase) assay

Phosphoenolpyruvate (50 mM): dissolve 21 mg of phosphoenolpyruvic acid in 2 mL of distilled H2O. Store at −20°C for 6 months. NADH (5 mM): dissolve 3.7 mg of β-Nicotinamide adenine dinucleotide (NADH) in 1 mL of distilled H2O. Prepare fresh before the assay. ATP (25 mM pH 7.0): add 7 mL of distilled H2O to 138 mg of adenosine triphosphate (ATP), dissolve by adjusting pH to 7.0 with 2 M NaOH. Adjust the volume to 10 mL. Prepare 1 mL-aliquots and store at −80°C for 6 months. Antimycin A (0.2 mg/mL): dissolve 1 mg of antimycin A in 5 mL of 100% ethanol. Store at −20°C for 6 months. CRITICAL: antimycin is highly toxic, handle it and dissolve under a fume hood using PPE. Oligomycin (5 mM): dissolve 4 mg of oligomycin in 1 mL 100% ethanol. Prepare 200 μL-aliquots and store at −20°C for 6 months.

Step-by-step method details

Isolation of mitochondria

Timing: 1–2 h Prior to measurement of mitochondrial respiratory chain enzymatic activities, mitochondria are prepared by differential centrifugation as described below. CRITICAL: samples must always be kept on ice, even during the homogenization step, using ice-cold buffers to minimize protein degradation. Homogenize samples in 2–3 mL of MS buffer with BSA, with 15–20 strokes at 1,000 rpm in a motor driven Teflon-glass Elvehjem potter on ice. Make sure the samples are always cold to avoid protein degradation. if a motor driven potter is not available, use a Dounce glass potter with a loose-fitting glass pestle for adults and third instar larvae and a tight-fitting glass pestle for thoraces and small larvae. CRITICAL: during the homogenization step, apply the same number of strokes to all the samples to obtain consistent results. Transfer the homogenate to a clean 30 mL centrifuge tube, rinse the potter with 7 mL of MS buffer with BSA and transfer to the tube with homogenate. Centrifuge the homogenate at 1,000 × g for 10 min at 4°C, to separate the liquid phase from debris, i.e., unbroken cells and nuclei. CRITICAL: centrifuge steps must be performed at 4°C to minimize sample degradation. Filter supernatant through a 100 μm strainer and transfer it into a new tube. filtering step is needed to remove legs, wings and cuticle debris that tend to float after homogenization. Centrifuge samples at 6,000 × g for 10 min at 4°C to pellet the mitochondrial fraction. CRITICAL: After the centrifugation steps, lipids are present as a white layer adhering to the tube walls. Make sure to remove lipids during the washing steps to avoid interference during measurement of enzymatic activities. Discard supernatant and resuspend the pellet with 10 mL of MS buffer with BSA. Repeat step 5. Remove the supernatant and resuspend the pellet with 10 mL of MS buffer without BSA. Centrifuge samples at 7,000 × g for 10 min at 4°C. Discard the supernatant and resuspend the pellet in 300–400 μL of MS buffer without BSA. Measure protein concentration with method of choice (e.g., Bradford, Lowry, or BCA). protein concentration should be measured in triplicate setting up a standard curve, to achieve good consistence and reliability of the results. this procedure yields crude mitochondrial fractions. Samples can be stored at −80°C for maximum 3 months. Avoid multiple freeze and thaw cycles of pellets to minimize degradation of protein complexes that can result in artifactual reduction of enzyme activities. Isolated mitochondria preparations can be stored in aliquots to avoid multiple freeze and thaw cycles. Pause point: Proceed with protocol or store samples at −80°C for up to 3 months.

Disruption of mitochondrial membranes

Timing: 0.5 h Prior to the activity assays, mitochondrial membranes need to be disrupted in order to allow access of the substrates to the MRC enzyme complexes. Pellet isolated mitochondria by centrifuging samples at 7,000 × g for 5 min at 4°C. depending on the type and the number of assays to be performed, evaluate the total amount of mitochondria needed for the experiment. For further details on the amounts of mitochondria needed for each assay, check the specific protocols below. Carefully discard supernatant and resuspend the pellet with hypotonic buffer (10 mM Tris-HCl pH 7.6) at 1 μg/μL final protein concentration. Snap-freeze in liquid nitrogen. Thaw at 25°C in a benchtop thermo shaker or, alternatively, in a water bath. Perform three freeze-thaw cycles to enhance mitochondrial membrane disruption. At this point, mitochondria should be immediately used, do not freeze them. Keep samples on ice during the enzymatic activity assays.

Measurement of mitochondrial respiratory chain enzymatic activities

The general concept behind measurement of the mitochondrial respiratory chain activities is to follow each enzymatic reaction through time. The enzyme kinetics is assessed via spectrophotometry by following variations in the UV-VIS absorbance of colorimetric substrates or reaction products. To date, most of UV-VIS plate readers and standard cuvette spectrophotometer can be set up to register absorbance during a time period. If a 96-well plate is used, as described in this protocol, we suggest following kinetic activity by registering absorbance values for 2 min, every 20 or 30 s, depending on the number of samples measured and reading speed of the plate reader at the desired wavelength. A plate reader is highly advised to measure multiple samples at the same time and to save reagents, as assays are carried out in 200 μL of reaction volume. If a standard cuvette spectrophotometer is used, adjust the reaction volume as needed. the measurement of mitochondrial respiratory chain enzymatic activities should be carried out at 30°C. allow reaction buffers to warm up at 20°C–25°C before the assays. enzyme activities should be measured at least in triplicate plus at least one replicate reaction in presence of a selective inhibitor to calculate specific activity.

Measurement of complex I (NADH:ubiquinone oxidoreductase) activity

Timing: 0.5–1 h Complex I is a NADH:ubiquinone oxidoreductase. Complex I is a starting point of the mitochondrial respiratory chain, the other being Complex II and other FADH2-dependent enzymes. It oxidizes NADH generated by the Krebs cycle in the mitochondrial matrix, passing two electrons through one flavin mononucleotide (FMN) and a series of iron-sulfur (Fe-S) clusters, to the electron carrier CoQ. The activity of complex I is measured through a direct method, following the decrease in absorbance at λ=340 nm due to the oxidation of NADH, carried out by the enzyme (Estornell et al., 1993; Spinazzi et al., 2012). For each replicate plus one (to ensure there is enough for all the samples), prepare the reaction mix as described in the following table: Add 186 μL of the reaction mix into each well of a 96- well plate (see key resources table), using a multichannel pipette. Add 10 μL of mitochondrial lysate from step 13 (1 μg/μL) and mix well. Record baseline activity at λ=340 nm for 2 min at 30°C. Add 4 μL of 4 mM CoQ1 (final concentration 80 μM) to each well to start the reaction. Make sure the substrate is mixed well in the reaction mix. Promptly record the absorbance at λ=340 nm for 2 min at 30°C. ∗To assess rotenone sensitive NADH-dehydrogenase activity (specific to mitochondrial complex I), perform parallel reactions in presence and absence of rotenone (complex I inhibitor). Expected outcomes for enzymatic activity assays (A) Complex I activity recordings of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + rotenone), plus recording of mitochondria from complex I subunit ND-18 (Ndufs4) gene knockdown D. melanogaster individuals (Mito CI KD), (Foriel et al., 2018). (B) Complex II activity recordings of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + Malonate). (C) Complex III activity recording of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + Antimycin A) plus recording of mitochondria from complex III assembly factor Bcs1 gene knockdown D. melanogaster individuals (Mito CIII KD), (Brischigliaro et al., 2021). (D) Complex IV activity recording of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + KCN) plus recording of mitochondria from complex IV assembly factor Coa8 gene knockdown D. melanogaster individuals (Mito CIV KD), (Brischigliaro et al., 2019). (E) Complex V activity recordings of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + Oligomycin). (F) CS activity recordings of wild-type mitochondria (Mito). expected results are reported in Figure 1A.
Figure 1

Expected outcomes for enzymatic activity assays

(A) Complex I activity recordings of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + rotenone), plus recording of mitochondria from complex I subunit ND-18 (Ndufs4) gene knockdown D. melanogaster individuals (Mito CI KD), (Foriel et al., 2018).

(B) Complex II activity recordings of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + Malonate).

(C) Complex III activity recording of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + Antimycin A) plus recording of mitochondria from complex III assembly factor Bcs1 gene knockdown D. melanogaster individuals (Mito CIII KD), (Brischigliaro et al., 2021).

(D) Complex IV activity recording of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + KCN) plus recording of mitochondria from complex IV assembly factor Coa8 gene knockdown D. melanogaster individuals (Mito CIV KD), (Brischigliaro et al., 2019).

(E) Complex V activity recordings of wild-type mitochondria in absence (Mito) or presence of the inhibitor (Mito + Oligomycin).

(F) CS activity recordings of wild-type mitochondria (Mito).

Measurement of complex II (succinate:coenzyme Q oxidoreductase) activity

Timing: 0.5–1 h Complex II is a succinate:coenzyme Q oxidoreductase - succinate dehydrogenase - that oxidizes succinate to fumarate during the sixth step of the TCA cycle in the mitochondrial matrix. It couples the oxidation to the reduction of the electron carrier CoQ. The activity of complex II is measured through an indirect method following the decrease in absorbance at λ=600 nm due to the reduction of DCPIP. DCPIP is reduced by CoQ1 from the transfer of electrons from succinate to CoQ through the activity of complex II (Trounce et al., 1996; Spinazzi et al., 2012). For each replicate plus one, prepare the reaction mix as described in the following table: Add 196 μL of the reaction mix into each well of a 96- well plate (see key resources table), using a multichannel pipette. Add 2 μL of mitochondrial lysate from step 13 (1 μg/μL) and mix well. Shake the plate for 5 s. Pre-incubate the plate at 25°C for 10 min. Record baseline activity at λ=600 nm for 2 min at 30°C. Add 2 μL of 4 mM CoQ1 (final concentration 40 μM) to each well to start the reaction. Shake the plate for 5 s, wait for 5 s. Record absorbance at λ=600 nm for 2 min at 30°C. ∗To subtract the contribution of unspecific reactions, perform parallel reactions in presence and absence of malonate (complex II inhibitor). During complex II activity assay, baseline activity reflects succinate dehydrogenase (SDH) activity, as complex II is able to reduce DCPIP when CoQ1 is not present, although at slower rate. Expected results are reported in Figure 1B.

Measurement of complex III (ubiquinol:cytochrome c oxidoreductase) activity

Timing: 0.5–1 h Complex III, also known as cytochrome bc1 complex, is a ubiquinol:cytochrome c oxidoreductase that catalyzes the electron transfer from ubiquinol (CoQ) to the second mobile electron carrier of the MRC, cytochrome c. The activity of complex III is measured through a direct method, following the increase in absorbance at λ=550 nm due to the reduction of cytochrome c, carried out by the enzyme (Trounce et al., 1996; Spinazzi et al., 2012). For each replicate plus one, prepare the reaction mix as described in the following table: Add 196 μL of the reaction mix into each well of a 96- well plate (see key resources table), using a multichannel pipette. Add 2 μL of mitochondrial lysate from step 13 (1 μg/μL) and mix well. Shake the plate for 5 s, wait for 5 s. Record baseline activity at λ=550 nm within 2 min at 30°C. Add 2 μL of 10 mM decylubiquinol (final concentration 100 μM) to each well to start the reaction. Shake the plate for 5 s, wait for 5 s. Record absorbance at λ=550 nm for 2 min at 30°C. ∗To subtract the contribution of possible unspecific reactions, perform parallel reactions in presence and absence of antimycin A (complex III inhibitor). It is crucial that the cytochrome c used for this assay is the product with Merk catalog number C7752, or similar (prepared with acetic acid without using TCA). Other kinds of cytochrome c isolated using other methods result in very high rates of unspecific cytochrome c reduction, greatly interfering with the assay. expected results are reported in Figure 1C.

Measurement of complex IV (cytochrome c oxidase) activity

Timing: 0.5–1 h Complex IV, or cytochrome c oxidase, is the terminal enzyme of the ETC. It catalyzes the oxidation of cytochrome c and the reduction of molecular oxygen (O2) to water (H2O). The activity of complex IV is measured through a direct method, following the decrease in absorbance at λ=550 nm due to the oxidation of reduced cytochrome c, carried out by the enzyme (Wharton and Tzagoloff, 1967; Trounce et al., 1996; Spinazzi et al., 2012). For each replicate plus one, prepare the reaction mix as described in the following table: Add 198 μL of the reaction mix into each well of a 96- well plate (see key resources table), using a multichannel pipette. Shake the plate for 5 s, wait for 5 s. Record baseline activity at λ=550 nm within 2 min at 30°C. Add 2 μL of mitochondrial lysate from step 13 (1 μg/μL), which will start the reaction. Mix well. Shake the plate for 5 s, wait for 5 s. Record absorbance at λ=550 nm for 2 min at 30°C. ∗To subtract the possible contribution of unspecific reactions, perform parallel reactions in presence and absence of KCN (complex IV inhibitor). expected results are reported in Figure 1D.

Measurement of complex V (ATP synthase) activity

Timing: 0.5–1 h Complex V is a F-type ATP synthase. It is a rotary enzyme that couples proton translocation, driven by the proton motive force (PMF) generated by proton translocation at the level of complexes I, III and IV, with ATP synthesis. It is also known as FOF1- ATP synthase. currently, no kinetic spectrophotometry-based methods are available for directly assessing ATP synthesis by ATP synthase. Therefore, the most commonly used methods are based on the evaluation of the reverse activity (ATP hydrolysis) of the enzyme, which have been proven useful to determine Complex V activity in isolated mitochondrial samples. A luminometric assay for measuring mitochondrial ATP synthesis was described before (Vives-Bauza et al., 2007). This activity is measured through an indirect method by linking its ATPase activity to NADH oxidation. Firstly, in presence of ADP (resulting from hydrolytic activity of ATP synthase), PEP is converted to pyruvate + ATP by pyruvate kinase. Then, pyruvate is converted to lactate by lactate dehydrogenase, through the oxidation of NADH, which is what this assay determines by measuring the decrease in absorbance at λ=340 nm. For each replicate plus one, prepare the reaction mix as described in the following table: Add 177 μL of the reaction mix into each well of a 96 well plate (see key resources table), using a multichannel pipette. Add 3 μL of mitochondrial lysate from step 13 (1 μg/μL) and mix well. Pre-incubate at 25°C for 5 min. Record baseline activity at λ=340 nm within 2 min at 30°C. Add 20 μL of 25 mM ATP pH 7.0 (final concentration 2.5 mM) to each well to start the reaction. Record absorbance at λ=340 nm for 2 min at 30°C. ∗To subtract the possible contribution of unspecific reactions, perform parallel reactions in presence and absence of oligomycin (complex V inhibitor). expected results are reported in Figure 1E.

Measurement of citrate synthase activity

Timing: 0.5–1 h Citrate synthase catalyzes the condensation of acetyl-CoA and oxaloacetate to form citrate during the first step of the Krebs cycle in the mitochondrial matrix. The activity of citrate synthase is often used as a reliable method of normalization of MRC activity assays. The activity of citrate synthase is measured through an indirect method, following the formation of a yellow-colored thionitrobenzoate (TNB) derivative of DTNB by measuring the changes in absorbance at λ=412 nm. DTNB spontaneously forms TNB by reacting with sulfhydryl groups of free coenzyme A resulting from citrate synthase activity (Srere, 1969; Trounce et al., 1996; Spinazzi et al., 2012). For each replicate plus one, prepare the reaction mix as described in the following table: Add 188 μL of the reaction mix into each well of a 96 well plate (see key resources table), using a multichannel pipette. Add 2 μL of mitochondrial lysate from step 13 (1 μg/μL) and mix well. Record baseline activity at λ=412 nm within 2 min at 30°C. Add 10 μL of 10 mM oxaloacetate (final concentration 500 μM) to each well to start the reaction. Record absorbance at λ=412 nm for 2 min at 30°C. expected results are reported in Figure 1F.

Expected outcomes

This protocol provides detailed methodology for measuring the activity of each individual MRC enzymatic complex and the FOF1-ATPase in isolated mitochondria from Drosophila tissues. The data collected with this procedure describe the kinetic enzyme activity of the MRC, which in turn provides quantitative data about the amount and/or functionality of the individual complexes in biological samples. This protocol records absorbance variations through time (ΔAbsorbance/minute - ΔA/min), which are used to calculate the enzymatic activity (Figure 1). The ΔA/min is calculated by subtracting the absorbance value at the end of the reaction to the absorbance value at the beginning of the reaction. Data collected can be plotted in Microsoft Excel and linear regression should be performed to evaluate R2 values of the reactions. Generally, R2>0.95 is considered a good result (Figure 1). For R2<0.95 we suggest repeating the measurement (see troubleshooting section), as this suggests non-linear reaction and unreliable assessment of enzymatic activity. Low R2 values for reactions in presence of inhibitors should not be considered problematic, as background variations in absorbance could contribute when low activities are recorded (Figure 1). Specific activity is assessed by subtracting ΔA/min values recorded in presence of specific inhibitors of MRC complexes to ΔA/min values recorded in absence of the inhibitor. Generally, good mitochondrial preparations have very low enzymatic activities in presence of the inhibitor (>85%–90% of activity inhibited), (Figure 1).

Enzyme activity calculations

To obtain quantitative enzymatic specific activity (SA) values, expressed as amount of substrate (nmol) converted per time unit (min) per mass unit (mg) of mitochondrial protein (nmol min-1 mg-1), use the following formula: The molar extinction coefficients (ε) at the specific wavelengths (λ) of the different molecules for which the absorbance is measured in each assay can be found in the following table: For example, the calculations for complex I activities reported in Figure 1A are: Mito control: . Mito rotenone: . Mito KD: .

Limitations

This method relies on the availability of enough amounts of tissue. For instance, if small larvae (e.g., 1st or 2nd instar larvae) and thoraces are being used, many individuals will be needed. Furthermore, dissection could be time consuming. In case of a complex experimental setup (e.g., many experimental conditions or genotypes) we suggest to prepare and store mitochondrial preparations before proceeding with the enzyme activity assays.

Troubleshooting

Problem 1

Low or no enzymatic activity observed for different MRC complexes.

Potential solution

Samples may be degraded, make sure you perform all the procedures on ice using ice-cold buffers, make sure samples are store at -80 for long periods of time and avoid multiple freeze and thaw cycles of the samples. Sample amount may be too low, try to increase sample amount until you observe linear reactions significantly higher than the background.

Problem 2

Non-linear reactions or plateau phase observed. Excessive amount of sample used for the activity assay. Reduce the amount of sample.

Problem 3

Activity observed during baseline recording. Contamination of buffers or reagents. Discard old reagents and prepare fresh solutions.

Problem 4

Low complex I activity. Oxidation of NADH. Prepare fresh NADH solution. NADH solution should be colorless or light yellow. Yellow color indicates oxidation of NADH.

Problem 5

High non-specific (rotenone-insensitive) complex I activity. Contamination with reticular or cytosolic NADH dehydrogenases. Thoroughly wash the mitochondrial pellets twice by resuspending in the appropriate amount of buffer. Make sure that centrifuge speed is correctly set.

Problem 6

Low complex II activity. Pre-incubation step was skipped. Pre-incubate mitochondria with assay solution at least 10 min before measuring the activity.

Problem 7

Low or no complex III activity. Carry over of potassium borohydride used for reduction of decylubiquinone. Avoid excess potassium borohydride. Make sure the decylubiquinol solution stops bubbling after addition of HCl. If bubbling does not stop after addition of 2–3 HCl aliquots, repeat centrifugation step and carefully avoid touching the bottom of the tube.

Problem 8

Low or no complex IV activity. Carry over of sodium dithionite used for reduction of cytochrome c. Avoid excess dithionite that can counteract complex IV activity.

Problem 9

Low or no complex V activity. Complex V activity assay relies on pyruvate kinase and lactate dehydrogenase activities. Store enzymes at 2°C–8°C.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Carlo Viscomi (carlo.viscomi@unipd.it).

Materials availability

This study did not generate new unique reagents.
REAGENT or RESOURCESOURCEIDENTIFIER
Chemicals, Peptides, and Recombinant Proteins

Acetyl coenzyme A lithium saltMerckA2181
Adenosine 5′-triphosphate disodium salt hydrateMerckA2383
Antimycin AMerckA8674
BSA (fatty acid free)MerckA6003
Coenzyme Q1MerckC7956
Cytochrome c from equine heartMerckC7752
D-MannitolMerckM4125
DCIP (2,6-Dichloroindophenol Sodium Salt Hydrate)MerckD1878
DecylubiquinoneMerckD7911
DTNB (5,5′-Dithiobis(2-nitrobenzoic acid))MerckD218200
EDTA (Ethylenediaminetetraacetic acid disodium salt dihydrate)MerckE1644
EGTA (Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid)MerckE3889
HEPES (N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid), 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid)MerckH3375
KCN (Potassium cyanide)Merck31252
L-Lactic Dehydrogenase from rabbit muscleMerckL2500
Magnesium chloride hexahydrateMerckM2670
Malonic acidMerckM1296
NADH (β-Nicotinamide adenine dinucleotide, reduced dipotassium salt)MerckN4505
Oligomycin from Streptomyces diastatochromogenesMerckO4876
Oxaloacetic acidMerckO4126
Phospho(enol)pyruvic acid monopotassium saltMerck860077
Potassium borohydrideMerck438472
Potassium phosphate dibasicMerckP2222
Potassium phosphate monobasicMerckP5655
Pyruvate Kinase from rabbit muscleMerckP1506
RotenoneMerckR8875
Sodium hydrosulphiteMerck157953
Sodium succinateMerckS2378
SucroseMerckS7903
TRIS baseMerckT1503
Tween-20MerckP7949

Experimental models: Organisms/strains

D. melanogaster strain expressing GAL4 under the control of the Act5c promoter. y[1] w[∗]; P{w[+mC]=Act5C-GAL4}25FO1/CyO, y[+]Bloomington Drosophila Stock CenterBDSC 4414
D. melanogaster strain expressing a transgenic RNAi construct for ND-18Vienna Drosophila Resource CenterVDRC 101489
D. melanogaster strain expressing a transgenic RNAi construct for Bcs1Bloomington Drosophila Stock CenterBDSC 51863
D. melanogaster strain expressing a transgenic RNAi construct for Coa8Vienna Drosophila Resource CenterVDRC 100605

Software and algorithms

ExcelMicrosoftOffice suite

Other

96-well clear flat bottom platesCorning3628
Thermo mixerEppendorf5382000015
Tissue grinderVWR432-0202
UV-VIS Spectrophotometer plate readerThermo Fisher ScientificVL0LA0D0
Stirrer motorIKA3593000
Centrifuge Tubes - 30 mLThermo Fisher Scientific3119-0030
Cell strainersCorning431752
Benchtop dewar flaskThermo Fisher Scientific4150-1000
ReagentFinal concentration
Mannitol225 mM
Sucrose75 mM
HEPES-KOH pH 7.45 mM
EGTA1 mM
ddH2On/a
Total200 mL

Store at 4°C for 1 week.

ReagentFinal concentration
Tris-HCl pH 8.00.2 M
Triton X-1000.2%
ddH2On/a
Total100 mL

Store at 4°C for 1 month.

ReagentFinal concentration
HEPES-KOH pH 8.00.1 M
MgCl210 mM
ddH2On/a
Total100 mL

Store at 4°C for 1 month.

ReagentStock concentrationVolume (μL)Final concentration
Potassium phosphate buffer pH 7.50.5 M2050 mM
BSA50 mg/mL123 mg/mL
KCN10 mM6300 μM
NADH5 mM4100 μM
H2O144
Rotenone∗1 mM210 μM
ReagentStock concentrationVolume (μL)Final concentration
Potassium phosphate buffer pH 7.50.5 M1025 mM
BSA50 mg/mL41 mg/mL
KCN10 mM6300 μM
Succinate400 mM1020 mM
DCPIP500 μM3075 μM
H2O136
Malonate∗1 M210 mM
ReagentStock concentrationVolume (μL)Final concentration
Potassium phosphate buffer pH 7.50.5 M1025 mM
EDTA pH 7.55 mM4100 μM
KCN10 mM10500 μM
Tween-202.5%20.025%
Cyt cox1 mM1575 μM
H2O155
Antimycin A∗1 mg/mL210 μg/mL
ReagentStock concentrationVolume (μL)Final concentration
Potassium phosphate buffer pH 7.00.1 M10050 mM
Cyt cred (1 mM)1 mM1575 μM
H2O83
KCN∗10 mM10500 μM
ReagentStock concentrationVolume (μL)Final concentration
HEPES/Mg Buffer pH=8.0100 mM / 10 mM10050 mM / 5 mM
NADH5 mM120.3 mM
Phosphoenolpyruvate50 mM102.5 mM
Pyruvate kinase10 mg/mL150 mg/mL
Lactate dehydrogenase5 mg/mL250 mg/mL
Antimycin A0.2 mg/mL22 mg/mL
H2O50
Oligomycin∗0.2 mg/mL22 μg/mL
ReagentStock concentrationVolume (μL)Final concentration
Tris-HCl pH 8.0 + 0.2% Triton X-1000.2 M100100 mM
DTNB in Tris-HCl pH 8.01 mM20100 μM
Acetyl-CoA (10 mM)10 mM6300 μM
H2O62
AssayReagentλ (nm)ε (mM-1 cm-1)
CINADH3406.22
CIIDCPIP60019.1
CIIICyt c55018.5
CIVCyt c55018.5
CVNADH3406.22
CSTNB41213.8
  9 in total

Review 1.  Assay of mitochondrial ATP synthesis in animal cells and tissues.

Authors:  Cristofol Vives-Bauza; Lichuan Yang; Giovanni Manfredi
Journal:  Methods Cell Biol       Date:  2007       Impact factor: 1.441

Review 2.  Biochemical assays of respiratory chain complex activity.

Authors:  Denise M Kirby; David R Thorburn; Douglass M Turnbull; Robert W Taylor
Journal:  Methods Cell Biol       Date:  2007       Impact factor: 1.441

3.  Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.

Authors:  I A Trounce; Y L Kim; A S Jun; D C Wallace
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

4.  Assay conditions for the mitochondrial NADH:coenzyme Q oxidoreductase.

Authors:  E Estornell; R Fato; F Pallotti; G Lenaz
Journal:  FEBS Lett       Date:  1993-10-11       Impact factor: 4.124

5.  Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells.

Authors:  Marco Spinazzi; Alberto Casarin; Vanessa Pertegato; Leonardo Salviati; Corrado Angelini
Journal:  Nat Protoc       Date:  2012-05-31       Impact factor: 13.491

6.  Feeding difficulties, a key feature of the Drosophila NDUFS4 mitochondrial disease model.

Authors:  Sarah Foriel; Julien Beyrath; Ilse Eidhof; Richard J Rodenburg; Annette Schenck; Jan A M Smeitink
Journal:  Dis Model Mech       Date:  2018-03-27       Impact factor: 5.758

7.  Knockdown of APOPT1/COA8 Causes Cytochrome c Oxidase Deficiency, Neuromuscular Impairment, and Reduced Resistance to Oxidative Stress in Drosophila melanogaster.

Authors:  Michele Brischigliaro; Samantha Corrà; Claudia Tregnago; Erika Fernandez-Vizarra; Massimo Zeviani; Rodolfo Costa; Cristiano De Pittà
Journal:  Front Physiol       Date:  2019-09-06       Impact factor: 4.755

8.  Clinical and molecular findings in children with complex I deficiency.

Authors:  M Bugiani; F Invernizzi; S Alberio; E Briem; E Lamantea; F Carrara; I Moroni; L Farina; M Spada; M A Donati; G Uziel; M Zeviani
Journal:  Biochim Biophys Acta       Date:  2004-12-06

9.  Modelling of BCS1L-related human mitochondrial disease in Drosophila melanogaster.

Authors:  Michele Brischigliaro; Elena Frigo; Samantha Corrà; Cristiano De Pittà; Ildikò Szabò; Massimo Zeviani; Rodolfo Costa
Journal:  J Mol Med (Berl)       Date:  2021-07-17       Impact factor: 4.599

  9 in total
  2 in total

1.  Mitochondrial Cytochrome c Oxidase Defects Alter Cellular Homeostasis of Transition Metals.

Authors:  Michele Brischigliaro; Denis Badocco; Rodolfo Costa; Carlo Viscomi; Massimo Zeviani; Paolo Pastore; Erika Fernández-Vizarra
Journal:  Front Cell Dev Biol       Date:  2022-05-19

2.  CG7630 is the Drosophila melanogaster homolog of the cytochrome c oxidase subunit COX7B.

Authors:  Michele Brischigliaro; Alfredo Cabrera-Orefice; Mattia Sturlese; Dei M Elurbe; Elena Frigo; Erika Fernandez-Vizarra; Stefano Moro; Martijn A Huynen; Susanne Arnold; Carlo Viscomi; Massimo Zeviani
Journal:  EMBO Rep       Date:  2022-06-14       Impact factor: 9.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.